The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

Autor: Brian Godman, Mainul Haque, Trudy Leong, Eleonora Allocati, Santosh Kumar, Salequl Islam, Jaykaran Charan, Farhana Akter, Amanj Kurdi, Carlos Vassalo, Muhammed Abu Bakar, Sagir Abdur Rahim, Nusrat Sultana, Farzana Deeba, M. A. Halim Khan, A. B. M. Muksudul Alam, Iffat Jahan, Zubair Mahmood Kamal, Humaira Hasin, Munzur-E-Murshid, Shamsun Nahar, Monami Haque, Siddhartha Dutta, Jha Pallavi Abhayanand, Rimple Jeet Kaur, Godfrey Mutashambara Rwegerera, Renata Cristina Rezende Macedo do Nascimento, Isabella Piassi Dias Godói, Mohammed Irfan, Adefolarin A. Amu, Patrick Matowa, Joseph Acolatse, Robert Incoom, Israel Abebrese Sefah, Jitendra Acharya, Sylvia Opanga, Lisper Wangeci Njeri, David Kimonge, Hye-Young Kwon, SeungJin Bae, Karen Koh Pek Khuan, Abdullahi Rabiu Abubakar, Ibrahim Haruna Sani, Tanveer Ahmed Khan, Shahzad Hussain, Zikria Saleem, Oliver Ombeva Malande, Thereza Piloya-Were, Rosana Gambogi, Carla Hernandez Ortiz, Luke Alutuli, Aubrey Chichonyi Kalungia, Iris Hoxha, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Ott Laius, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuoliene, Jolanta Gulbinovič, Magdalene Wladysiuk, Jakub Rutkowski, Ileana Mardare, Jurij Fürst, Stuart McTaggart, Sean MacBride-Stewart, Caridad Pontes, Corinne Zara, Eunice Twumwaa Tagoe, Rita Banzi, Janney Wale, Mihajlo Jakovljevic

Publikováno v: Frontiers in Public Health, Vol 9 (2021)

Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control inclu

Externí odkaz: https://doaj.org/article/21e165a45cc44a40aaaa93c7005bfdad

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries

Autor: Paweł Kawalec, Ewa Stawowczyk, Tomas Tesar, Jana Skoupa, Adina Turcu-Stiolica, Maria Dimitrova, Guenka I. Petrova, Zinta Rugaja, Agnes Männik, Andras Harsanyi, Pero Draganic

Publikováno v: Frontiers in Pharmacology, Vol 8 (2017)

Objectives: The aim of this study was to review the requirements for the reimbursement of biosimilars and to compare the reimbursement status, market share, and reimbursement costs of biosimilars in selected Central and Eastern European (CEE) countri

Externí odkaz: https://doaj.org/article/ce1342996d2647398a53000ed330f02b

L'adaptation des enseignants et l'enseignement du droit pendant la pandémie

Autor: András Hárs, Isabella Brink Møller, Kaitlin Berger, João Casqueira Cardoso

Publikováno v: População e Sociedade, Iss 37, Pp 1-16 (2022)

La pandémie de SARS-CoV-2 a perturbé profondément la façon dont les enseignants universitaires travaillent, et la façon dont les étudiants étudient. L’enseignement en distanciel a apporté avec lui des solutions pédagogiques, mais l’exp

Externí odkaz: https://doaj.org/article/57adc776387b408bb428a717c2f59d19

Causes and Effects of Uruguay’s Contribution to the United Nations’ Peace Operations

Autor: András Hárs

Publikováno v: Academic and Applied Research in Military and Public Management Science. 21:71-83

Latin American States have been ardent defenders of international peace and security for several decades. Preeminent among them is the state of Uruguay, which has contributed a substantial amount of military and police personnel to United Nations pea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b918a70f9e4f47a33cbf55573cd03684
https://doi.org/10.32565/aarms.2022.3.4

A MESTERSÉGES INTELLIGENCIA NEMZETKÖZI SZERVEZETEK ÁLTALI SZABÁLYOZÁSÁNAK ÖSSZEHASONLÍTÁSA AZ EMBERI JOGOK SZEMÜVEGÉN ÁT. (Hungarian)

Autor: András, Hárs

Publikováno v: Pro Publico Bono - Magyar Közigazgatas; 2023, Vol. 11 Issue 2, p125-143, 19p